Controlled label artwork on a packaging render. Physical print fit and production photography are pending.
50 mL · 8% w/v + 5% w/v
Pricing, packaging, and release details are not configured.
Independent raw-material report available
This report applies to the RU58841 powder batch used as source material. It does not test or verify the concentration, vehicle, or finished formulation.
For research use only. Not for human consumption. Not for application to humans or animals.
A planned higher-concentration dual-compound 50 mL research formulation. Vehicle details are intentionally not published.
No product-linked documents are currently attached.
The public Janoshik report covers source raw-material batch MLP-RU-20260803. It is shown as upstream evidence and not as finished-formulation verification.
Discreet packaging uses a neutral outer package. Mandatory carrier, sender, and address labels remain visible.
Preparation after confirmed payment is the intended workflow. Any freshness timestamp or seven-day handoff statement will be shown only when the recorded fulfillment timestamps support it; it is not a potency guarantee.
Storage information will be published with the released product documentation.
Read the full shipping policy →Vehicle composition can influence solubility, thermodynamic activity, skin retention, and permeation. These properties cannot be reduced to a universal strength claim.
Read: Understanding Transcutol →